Trial Profile
Open-label exploratory investigation of NPL-2003 in adolescents with obsessive compulsive disorder.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 May 2012
Price :
$35
*
At a glance
- Drugs NPL 2003 (Primary)
- Indications Obsessive-compulsive disorders
- Focus Therapeutic Use
- 26 Apr 2012 Actual patient number is 6 according to ClinicalTrials.gov.
- 27 Aug 2007 New trial record.